Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...

The Real Housewives of Potomac matriarch was found guilty after a two-day trial and more than five hours of jury deliberation, following a March 2024 car accident where she swerved to avoid ...

Viking Therapeutics has seen a significant drop, despite positive news and promising GLP-1 drug developments. Find out why ...

Tyler Perry reminds us that starting therapy is never too late. The director was recently a guest on The View and revealed that he began therapy for the first time at 54. Perry said a question ...

Love was in the air throughout 2024! While some of our favorite celebrity Black couples, like Gabrielle Union and Dwayne Wade, Ciara, and Russell Wilson, Steve and Marjorie Harvey, and Jay Z and ...

"Time is of the essence," U.N. political affairs chief Rosemary DiCarlo told the Security Council, which enshrined the deal in a 2015 resolution. "While the onus is on the JCPOA participants and ...

Novo Nordisk's U.S.-listed shares sank over 19% in premarket trading Friday after releasing trial results for its next generation of weight loss drug, meant to add to its current lineup of Ozempic and ...

A more recent 2024 study — also funded by Novo Nordisk — is currently the longest clinical trial on semaglutide for weight loss. It looked at almost 18,000 participants with excess weight or ...

Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...

Novo Nordisk’s (NVO) next-gen weight loss therapy, CagriSema, caused up to ~23% of weight loss compared to ~16% of weight ...